Eyal Attar

No open positions remaining

55 year

Health Technology

Consumer Services

Profile

Eyal C.
Attar formerly worked at Agios Pharmaceuticals, Inc., as Senior Medical Director from 2016 to 2019, Harvard Medical School, as Member-Leukemia Center, Aprea Therapeutics, Inc., as Chief Medical Officer & Senior Vice President, and Vor Biopharma, Inc., as Chief Medical Officer from 2022 to 2025.
Dr. Attar received his doctorate degree from UNC School of Medicine.

Former positions of Eyal Attar

Companies	Position	End
VOR BIOPHARMA INC.	Chief Tech/Sci/R&D Officer	18/04/2025
AGIOS PHARMACEUTICALS, INC.	Chief Tech/Sci/R&D Officer	01/01/2019
Harvard Medical School Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University	Corporate Officer/Principal	-
APREA THERAPEUTICS, INC.	Chief Tech/Sci/R&D Officer	-

See the detail of Eyal Attar's experience

Training of Eyal Attar

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Eyal Attar's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	5
Agios Pharmaceuticals, Inc. Agios Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics	Health Technology
Harvard Medical School Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
UNC School of Medicine UNC School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Vor Biopharma, Inc. Vor Biopharma, Inc. BiotechnologyHealth Technology Engages in developing cell therapies	Health Technology
Aprea Therapeutics, Inc. Aprea Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops novel anticancer compounds	Health Technology

See company connections